arrow
R

Ross Cranston

Hospital Clínic de Barcelona
H指数:36
被引数:4,834

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy

奥贝法莫德对接受抑制性抗逆转录病毒治疗的人类免疫缺陷病毒患者的病毒持久性,炎症和免疫激活的影响

2023-07-035
OAAI
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis
AIDS
IF3.1
2021-04-0912
OA
Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV
AIDS
IF3.1
2020-09-1717
OA
Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
2020-09-0113
OAAI
Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus
2019-07-1136
OAAI
A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial
2018-07-2743
OAAI
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

在27岁或以上的人类免疫缺陷病毒感染的成年人中进行四价人乳头瘤病毒疫苗的随机,安慰剂对照试验: AIDS临床试验组方案A5298

2018-04-05105
OAAI
Challenges and solutions implementing an SMS text message-based survey CASI and adherence reminders in an international biomedical HIV PrEP study (MTN 017)

挑战和解决方案在国际生物医学HIV PrEP研究中实施基于SMS文本消息的调查CASI和依从性提醒 (MTN 017)

2018-04-0119
OAAI
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
2016-12-1344
OAAI
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
2016-12-0180
OAAI
Association of serum cytokines with oral HPV clearance
2016-07-0110
OAAI
Mucosal effects of tenofovir 1% gel
2015-02-0345
OA